Authors: Morse, MA Clay, TM Hobeika, AC Mosca, PJ Lyerly, HK

Citation: Ma. Morse et al., Surrogate markers of response to cancer immunotherapy, EXPERT OP B, 1(2), 2001, pp. 153-158

Authors: Clay, TM Hobeika, AC Mosca, PJ Lyerly, HK Morse, MA

Citation: Tm. Clay et al., Assays for monitoring cellular immune responses to active immunotherapy ofcancer, CLIN CANC R, 7(5), 2001, pp. 1127-1135

Authors: Hobeika, AC Clay, TM Mosca, PJ Lyerly, HK Morse, MA

Citation: Ac. Hobeika et al., Quantitating therapeutically relevant T-cell responses to cancer vaccines, CR R IMMUN, 21(1-3), 2001, pp. 287-297

Authors: Mosca, PJ Hobeika, AC Clay, TM Morse, MA Lyerly, HK

Citation: Pj. Mosca et al., Direct detection of cellular immune responses to cancer vaccines, SURGERY, 129(3), 2001, pp. 248-254

Authors: Mosca, PJ Hobeika, AC Clay, TM Nair, SK Thomas, EK Morse, MA Lyerly, HK

Citation: Pj. Mosca et al., A subset of human monocyte-derived dendritic cells expresses high levels of interleukin-12 in response to combined CD40 Ligand and interferon-gamma treatment, BLOOD, 96(10), 2000, pp. 3499-3504